Boston Scientific Corporation Securities Litigation
On or around 09/20/2019 (Stipulation and order of dismissal (voluntary dismissal))
Filing Date: April 24, 2019
According to the Complaint, Boston Scientific Corporation y develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Boston Scientific’s surgical mesh products indicated for the transvaginal repair of POP were unsafe; (ii) accordingly, Boston Scientific’s continued marketing and sales of these devices in the United States was unlikely to be sustainable; (iii) separately, the Company had sold vaginal mesh implants containing counterfeit or adulterated resin products imported from China; (iv) the foregoing conduct subjected the Company to a heightened risk of regulatory scrutiny and/or government investigations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
On June 18, 2019, the Court issued an Order transferring the case to the District Court for the District of Massachusetts. The Court issued an Order appointing Lead Plaintiff and Counsel on July 17. Lead Plaintiff voluntarily dismissed the claims on September 20, 2019.
Company & Securities Information
Defendant: Boston Scientific Corporation
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: BSX
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Steve Klein, et al. v. Boston Scientific Corporation, et al.